Charvi Nanavati

Charvi Nanavati is a seasoned professional in clinical pharmacology, currently serving as the Director of Clinical Pharmacology in Oncology at Pfizer since April 2022, after holding the position of Associate Director in the same department. Prior to joining Pfizer, Charvi was with Ionis Pharmaceuticals, Inc. for nearly four years, advancing from Assistant Director to Associate Director of Clinical Pharmacology and Pharmacokinetics. Charvi's career in clinical research began at Halozyme, Inc. as a Senior Scientist I and a Research Scientist II, following an internship at Novartis and a summer internship at Pfizer. Academic credentials include a PhD in Pharmaceutical Sciences with a focus on Systems Pharmacology, Pharmacokinetics, and Pharmacodynamics from the University at Buffalo, as well as a Master's in Pharmaceutical Sciences from the same institution and a Bachelor's in Pharmaceutical Sciences from the Institute of Chemical Technology.